Want to see NL:VVY full AI Analyst Report?
Vivoryon Therapeutics AG (VVY) Income Statement
Vivoryon Therapeutics AG Income Statement
Last quarter (Q2 2026), Vivoryon Therapeutics AG's total revenue was $0.00. In Q2, Vivoryon Therapeutics AG's net income was $-3.39M. See Vivoryon Therapeutics AG’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ -3.62M | $ 0.00 | $ 10.76M | |
| $ -147.00K | $ -147.00K | $ -3.10M | $ -161.00K | $ 9.03M | |
| $ 9.03M | $ 20.81M | $ 25.74M | $ 28.97M | $ 21.84M | |
| Depreciation and Amortization | $ 147.00K | $ 147.00K | $ 167.00K | $ 161.00K | $ 165.00K |
| $ -9.03M | $ -20.34M | $ -28.35M | $ -28.17M | $ -12.03M | |
| $ -9.18M | $ -20.96M | $ -28.84M | $ -29.13M | $ -12.81M | |
| $ 324.00K | $ 393.00K | $ 261.00K | $ 777.00K | $ 575.00K | |
| $ -8.85M | $ -20.57M | $ -28.58M | $ -28.36M | $ -12.22M | |
| $ -8.85M | $ -20.57M | $ -28.34M | $ -28.16M | $ -12.65M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.33 | $ -0.79 | $ -1.12 | $ -1.28 | $ -0.63 |
| Diluted EPS | $ -0.33 | $ -0.79 | $ -1.12 | $ -1.28 | $ -0.63 |
| Weighted Average Shares Outstanding | 26.99M | 26.04M | 25.24M | 22.02M | 20.00M |
| Weighted Average Shares Outstanding (Diluted) | 26.99M | 26.04M | 25.24M | 22.02M | 20.00M |
Currency in EUR
